PA health systems expert Steve Black has been quoted in the Financial Times. Steve gives his views on the implications of a new model of payment by results which is emerging in healthcare.
Commenting on the process of linking pharmaceutical prices more closely to patient outcomes, Steve says: “It is not uncommon for some classes of drugs to be effective in only one in three patients who take them.”
Steve cites anti-cancer treatments and psychoactive medicines as examples and concludes: “We might have to spend tens of thousands before knowing whether a drug will have any effect."
You can read Steve's views on data management here
To visit PA's heathcare pages, click here